| Trial ID: | L5961 |
| Source ID: | NCT01274663
|
| Associated Drug: |
Pf-05175157 Or Placebo
|
| Title: |
A Study Of PF-05175157 In Healthy Volunteers
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: PF-05175157 or Placebo|DRUG: PF-05175157 or Placebo|DRUG: PF-05175157 or Placebo|DRUG: PF-05175157 or Placebo|DRUG: PF-05175157 or Placebo|DRUG: PF-05175157 or Placebo|DRUG: PF-05175157 or Placebo
|
| Outcome Measures: |
Primary: Safety and tolerability of escalating single doses of PF-05175157 in healthy subjects, 5 months|Single dose pharmacokinetics of PF-05175157, 5 months | Secondary: Exploratory pharmacodynamic biomarkers, 5 months
|
| Sponsor/Collaborators: |
Sponsor: Pfizer
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
63
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2010-11
|
| Completion Date: |
2011-05
|
| Results First Posted: |
|
| Last Update Posted: |
2011-10-12
|
| Locations: |
Pfizer Investigational Site, South Miami, Florida, 33143, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01274663
|
